Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

33.92
+0.01000.03%
Pre-market: 33.86-0.0600-0.18%08:38 EST
Volume:2.97M
Turnover:100.74M
Market Cap:39.52B
PE:28.03
High:34.22
Open:33.69
Low:33.52
Close:33.91
52wk High:37.35
52wk Low:12.47
Shares:1.17B
Float Shares:1.14B
Volume Ratio:0.40
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.21
EPS(LYR):1.21
ROE:20.79%
ROA:6.17%
PB:5.00
PE(LYR):28.03

Loading ...

Feb 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 28, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Dec 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Sep 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Major Issues Report

Form 8-K - Current report